ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
ADARx Pharmaceuticals, Inc.
$17.63−0.02 (-0.11%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
ADARx Pharmaceuticals has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements ADARx Pharmaceuticals filed with the SEC
Current report on Form 8-K
Event dated Sep 28, 2026, from SEC EDGAR